03 — Consortium
Six institutions, four countries.
Coordinated from Antwerp, with clinical and research partners in South Africa, Benin and Kenya.
Project coordinator · Belgium
Institute of Tropical Medicine, Antwerp
ITM coordinates the project and its scientific and financial management. It also leads the research on acceptability and feasibility (WP3) and the project management.
South Africa
Desmond Tutu TB Centre, Stellenbosch University
Leads the Actiphage® trial (WP1), the chest X-ray work (WP4) and the scientific coordination.
South Africa
University of Cape Town
Leads the health-economic evaluation of the tools (WP3).
Benin
CNHU-PPC, Cotonou
Centre National Hospitalier Universitaire de Pneumo-Phtisiologie. Trial site in Benin; leads communication, dissemination and training (WP5).
Kenya
The Aga Khan University
Leads the development and validation of the CDM-app (WP2).
Kenya
KEMRI-Wellcome Trust Research Programme
Research partner in Kenya supporting the CDM-app development.
Across the consortium: clinical, laboratory, data science, health economics and social science expertise, in sub-Saharan Africa and Europe.